Abstract
Since the pioneering work of Furchgott and Zawadzki (1980), it has become increasingly clear that the vascular endothelium plays a key role in the regulation of the cardiovascular system. The discovery in 1987 that nitric oxide (NO) accounts for the vasorelaxing action of the endothelium (Ignarro et al. 1987; Palmer et al. 1987), opening the possibility of specifically inhibiting NO synthesis, greatly enlarged our understanding of endothelial physiology and gave rise to a vast new area of biological knowledge: NO physiology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnal JF, Warin L, & Michel JB. 1992. Determinants of aortic cyclic guanosine monophos-phate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest 90:647–652.
Bachmann S, & Mundel P. 1994. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 24:112–129.
Bank N, Aynedjian HS, & Khan GA. 1994. Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats. Hypertension 24:322–328.
Baylis C, & Qiu CB. 1996. Importance of nitric oxide in the control of renal hemodynam-ics, Kidney Int 49: 1727–1731.
Baylis C, Mitruka B, & Deng A. 1992. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90:278–281.
Baylis C, Harvey J, & Engels K. 1994. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II. J Am Soc Nephrol 5:211–214.
Bonnardeaux A, Nadaud S, Charm A, Jeunemaitre X, Corvol P, & Soubrier F, 1995. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation 91:96–102.
Bouriquet N, Dupont M, Herizi A, Mimran A, & Casellas D. 1996. Preglomerular su-danophilia in L-NAME hypertensive rats: involvement of endothelin. Hypertension 27:382–391.
Calver A, Collier J, & Vallance P. 1994. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension. Cardiovasc Res 28:1720–1725.
Chen PY, & Sanders PW. 1991. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 88:1559–1561.
Cockcroft JR, Chowienczyk PJ, Benjamin N, & Ritter JM. 1994. Preserved endothelium-dependent vasodilation in patients with essential hypertension. N Engl J Med 330:1036–1040.
Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, & Cooke JP. 1992. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90:1248–1253.
Erley CM, Rebmann S, Strobel U, Schmidt T, Wehrmann M, Osswald H, & Risler T. 1995. Effects of antihypertensive therapy on blood pressure and renal function in rats with hypertension due to chronic blockade of nitric oxide synthesis. Exp Nephrol 3:293–299.
Fernandezrivas A, Garciaestan J, & Vargas F. 1995. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J Hypertens 15:123–128.
Fujihara CK, Michellazzo SM, De Nucci G, & Zatz R. 1994. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Phys-iol 266:F697–F705.
Furchgott RF, & Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376.
Granger J, Novak J, Schnackenberg C, Williams S, & Reinhart GA. 1996. Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension 27:613–618.
Guyton AC. 1990. Long term arterial pressure control: an analysis from animal experiments and computer and graphic models. Am J Physiol 259:R865–R877.
Harada S, Tokunaga S, Momohara M, Masaki H, Tagawa T, Imaizumi T, & Takeshita A. 1993. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 72:511–516.
Haynes WG, Noon JP, Walker BR, & Webb DJ. 1993. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 11:1375–1380.
Huang PL, Huang ZH, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, & Fishman MC. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239–242.
Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, & Moskowitz MA. 1996. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 16:981–987.
Hunt SC, Williams CS, Sharma AM, Inoue I, Williams RR, & Lalouel JM. 1996. Lack of linkage between the endothelial nitric oxide synthase gene and hypertension. J Hypertens 10:27–30.
Ignarro LJ, Buga GM, Wood KS, Byrns RE, & Chaudhuri G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265–9269.
Imaizumi T, Hirooka Y, Masaki H, Harada S, Momohara M, Tagawa T, & Takeshita A. 1992. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension 20:511–517.
Ito A, Egashira K, Kadokami T, Fukumoto Y, Takayanagi T, Nakaike R, Kuga T, Sueishi K, Shimokawa H, & Takeshita A. 1995. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation 92:2636–2644.
Joannides R, Haefeli WE, Under L, Richard V, Bakkali EH, Thuillez C, & Luscher TF. 1995. Nitric oxide is responsible for flow-dependent dilation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319.
Johnson RA, & Freeman RH. 1992. Sustained hypertension in the rat induced by chronic blockade of nitric oxide production. Am J Hypertens 5:919–922.
Jover B, Herizi A, Ventre F, Dupont M, & Mimran A. 1993. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 21:944–948.
Kassab S, Miller MT, Hester R, Novak J, & Granger JP. 1998. Systemic hemodynamics and regional blood flow during chronic nitric oxide synthesis inhibition in pregnant rats. Hypertension 31:315–320.
Kone BC, & Baylis C. 1997. Biosynthesis and homeostatic roles of nitric oxide in the kidney. Am J Physiol 272:F561–F578.
Lahera V, Salazar J, Salom MG, & Romero JC. 1992. Deficient production of nitric oxide induces volume-dependent hypertension. J Hypertens Suppl 10:S173–S177.
Larson TS, & Lockhart JC. 1995. Restoration of vasa recta hemodynamics and pressure na-triuresis in SHR by L-arginine. Am J Physiol Renal Fluid Electrolyte Physiol 37:F907–F912.
Laubach VE, Shesely EG, Smithies O, & Sherman PA. 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92:10688–10692.
Lyons D, Webster J, & Benjamin N. 1994. The effect of antihypertensive therapy on responsiveness to local intra-arterial N-G-monomethyl-L-arginine in patients with essential hypertension. J Hypertens 12:1047–1052.
Maiese K, Boniece IR, Skurat K, & Wagner JA. 1993. Protein kinases modulate the sensitivity of hippocampal neurons to nitric oxide toxicity and anoxia. J Neurosci Res 36:77–87.
Manning RD, Hu LF, & Williamson TD. 1994. Mechanisms involved in the cardiovascular-renal actions of nitric oxide inhibition. Hypertension 23:951–956.
Matsuoka H, Nishida H, Nomura G, Vanvliet BN, & Toshima H. 1994. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 23:971–975.
Mattson D, & Higgins DJ. 1996. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 27:688–692.
Mattson DL, Lu S, Nakanishi K, Papanek PE, & Cowley AW Jr. 1994. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol 266:H1918–H1926.
Michel JB, Xu YC, Blot S, Philippe M, & Chatellier G. 1996. Improved survival in rats administered N-G-nitro L-arginine methyl ester due to converting enzyme inhibition. J Cardiovasc Pharmacol 28:142–148.
Moncada S, Palmer RMJ, & Higgs EA. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109–141.
Moreno H, Nathan LP, Costa SKP, Metze K, Antunes E, Zatz R, & De Nucci G. 1995. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol 287:93–96.
Moreno H, Metze K, Bento AC, Antunes E, Zatz R, & De Nucci G. 1996. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol 91:248–255.
Moreno H, Nathan LP, Metze K, Costa SKP, Antunes E, Hyslop S, Zatz R, De Nucci G. 1997. Non-specific inhibitors of nitric oxide synthase cause myocardial necrosis in the rat. Clin Exp Pharmacol Physiol 24:349–352.
Morikawa E, Huang Z, & Moskowitz MA. 1992. L-Arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am J Physiol 263:H1632–H1635.
Morton JJ, Beattie EC, Speirs A, & Gulliver F. 1993. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hy-pertrophy. J Hypertens 11:1083–1088.
Nakashima A, Matsuoka H, Yasukawa H, Kohno K, Nishida H, Nomura G, Imaizumi T, & Morimatsu M. 1996. Renal denervation prevents intraglomerular platelet aggregation and glomerular injury induced by chronic inhibition of nitric oxide synthesis. Nephron 73:34–40.
Navarro-Cid J, Maeso R, Rodrigo E, Munoz-Garcia R, Ruilope LM, Lahera V, & Cachofeiro V. 1996. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens 9:1077–1083.
Nelson RJ, Demas GE, Huang PL, Fishman MC, Dawson VL, Dawson TM, & Snyder SH. 1995. Behavioral abnormalities in male mice lacking neuronal nitric oxide synthase. Nature 23:383–386.
Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, & Takeshita A. 1995. Chronic inhibition of nitric oxide synthesis causes coronary mi-crovascular remodeling in rats. Hypertension 26:957–962.
Palmer RMJ, Ferrige AG, & Moncada S. 1987. Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature 327:524–526.
Panza JA, Casino PR, Kilcoyne CM, & Quyyumi AA. 1993. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87:1468–1474.
Pollock DM, Polakowski JS, Divish BJ, & Opgenorth TJ. 1993. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 21:660–666.
Prado R, Watson BD, Kuluz J, & Dietrich WD. 1992. Endothelium-derived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke 23:1118–1123.
Preik M, Kelm M, Feelisch M, & Strauer BE. 1996. Impaired effectiveness of nitric oxide-donors in resistance arteries of patients with arterial hypertension. J Hypertens 14:903–908.
Qiu C, Engels K, & Baylis C. 1994. Angiotensin II and alpha l-adrenergic tone in chronic nitric oxide blockade-induced hypertension. Am J Physiol 266:R1470–R1476.
Qiu C, Beierwaltes W, Racusen L, Muchant D, & Baylis C. 1998. Evolution of chronic nitric oxide inhibition hypertension: relationship to renal function. Hypertension 31:21–26.
Rees DD, Palmer RMJ, & Moncada S. 1989. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc NatlAcad Sci USA 86:3375–3378.
Reinhart GA, Lohmeier TE, & Mizelle HL. 1997. Temporal influence of the renal nerves on renal excretory function during chronic inhibition of nitric oxide synthesis. Hypertension 29:199–204.
Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, & Zatz R. 1992. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 20:298–303.
Ribeiro MO, Antunes E, Muscara MN, De Nucci G, & Zatz R. 1995. Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition. Hypertension 26:150–155.
Salazar FJ, Alberola A, Pinilla JM, Romero JC, & Quesada T. 1993. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 22:49–55.
Sander M, Hansen J, & Victor RG. 1997. The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by N-omega-nitro-L-arginine methyl ester. Hypertension 30:64–70.
Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, & Smithies O. 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93:13176–13181.
Sigmon DH, Carretero OA, & Beierwaltes WH. 1992. Plasma renin activity and the renal response to nitric oxide synthesis inhibition. J Am Soc Nephrol 3:1288–1294.
Sventek P, Turgeon A, & Schiffrin EL. 1997. Vascular endothelin-l gene expression and effect on blood pressure of chronic ET(A) endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation 95:240–244.
Takahashi H, Hara K, Komiyama Y, Masuda M, Murakami T, Nishimura M, Nambu A, & Yoshimura M. 1995. Mechanism of hypertension induced by chronic inhibition of nitric oxide in rats. Hypertens Res 15:319–324.
Takase H, Moreau P, Kung CF, Nava E, & Luscher TF. 1996. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effect of verapamil and trandolapril. Hypertension 27:25–31.
Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, & Takeshita A. 1997. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 99:278–287.
Tolins JP, & Shultz PJ. 1994. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 46:230–236.
Traystman RJ, Moore LE, Helfaer MA, Davis S, Banasiak K, Williams M, & Hum PD. 1995. Nitro-L-arginine analogues. Dose and time related nitric oxide inhibition in brain. Stroke 26:864–869.
Trifiletti RR. 1992. Neuroprotective effects of N G-nitro-L-arginine in focal stroke in the 7-day old rat. Eur J Pharmacol 218:197–198.
Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, & Yen MH. 1996. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 27:36–42.
Warren JB. 1994. Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light. FASEB J 8:247–251.
Wolzt M, Schmetterer L, Ferber W, Artner E, Mensik C, Eichler HG, & Krejcy K. 1997. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Am J Physiol Renal Physiol 41: F178–F182.
Yamada SS, Sassaki AL, Fujihara CK, Malheiros DMAC, De Nucci G, & Zatz R. 1996. Effect of salt intake and inhibitor dose on arterial hypertension and renal injury induced by chronic nitric oxide blockade. Hypertension 27:1165–1172.
Zanchi A, Schaad NC, Osterheld MC, Grouzmann E, Nussberger J, Brunner HR, & Waeber B. 1995. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system. Am J Physiol 268:H2267–H2273.
Zatz R, & De Nucci G. 1991. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 267:F360–F363.
Zhang K, Mayhan WG, Patel KP. 1997. Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity. Am J Physiol 273:R864–R872.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Zatz, R., Baylis, C. (2000). Nitric Oxide and Hypertension. In: Kadowitz, P.J., McNamara, D.B. (eds) Nitric Oxide and the Regulation of the Peripheral Circulation. Nitric Oxide in Biology and Medicine, vol 1. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-1326-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1326-0_7
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4612-7095-9
Online ISBN: 978-1-4612-1326-0
eBook Packages: Springer Book Archive